This study is looking at whether using a GPS tracker device can help people experiencing unsheltered homelessness stick to their Hepatitis C (HCV) treatment. Hepatitis C is a liver infection caused by a virus. Researchers want to see if this device improves how well participants take their medication and how long their treatment lasts. You might be able to join if you have Hepatitis C, are experiencing unsheltered homelessness, speak English or Spanish, and are receiving care from a street medicine program. The study will compare people who receive standard Hepatitis C care with those who receive standard care plus the GPS tracker. The main goals are to measure how well participants take their medication and the total length of their treatment, both measured at 8-12 weeks.

Study design

This is an interventional study planning to enroll 124 participants. Participants will be randomly assigned to either receive standard medical care for Hepatitis C or standard medical care plus a GPS tracking device.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Medication adherence and treatment length will be measured at 8-12 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.